Plasma-Derived Products

This line will be dedicated to the manufacturing of medicinal products derived from human plasma, such as albumin, immunoglobulins, and coagulation factors. These products are essential for the treatment of immune deficiencies, hemophilia, autoimmune diseases, and for use in intensive care. They address critical public health needs in Algeria and aim to reduce reliance on imports.